Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: ACTELION PHARMACEUTICALS US, INC.
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2023-02-04 to 2024-02-03
Current total value of award: $83952.6
Description: SPECIALTY MEDICATIONS